Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Parallel Industries Inc. EAPH OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
49/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Parallel Industries Inc. (EAPH) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 12.9% (+0 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

Analyst outlook: 2 / 2 analysts rate EAPH as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Fail), Moat 18/100 (Fail), Future 100/100 (Pass), Income ?/100 (Fail).

EAPH SharesGrow Score Overview

61/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 18/100
Gross margin is + market cap
FUTURE 100/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — EAPH

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
EAPH: -100%/yr revenue is, +70.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
67/100
Balance sheet EAPH: Debt-to-Equity (D/E) ratio N/A, Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
18/100
EAPH: Gross margin is 12.9% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 18/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
100/100
Analyst outlook: 2 / 2 analysts rate EAPH as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.0001
Volume1K
Avg Volume (30D)90.47K
Market Cap$9.33K
Beta (1Y)27.13
Share Statistics
IPO Date1999-09-13
Employees6
CEOEvan Karras
Financial Highlights & Ratios
Analyst Forecast
Rating ConsensusBuy
Analysts Covering2
Buy 100% Hold 0% Sell 0%
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINUS2777741057

Price Chart

Track all markets on TradingView
EAPH
Parallel Industries Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

ELTP
ELTP
Elite Pharmaceuticals, Inc.
$0.38
+0.26%
 INCR
INCR
InterCure Ltd.
$0.75
-1.49%
 ITHUF
ITHUF
iAnthus Capital Holdings, Inc.
$0.00
+5.52%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 MCUJF
MCUJF
Medicure Inc.
$0.96
+0.00%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-4.57%
 USMJ
USMJ
North American Cannabis Holdings, Inc.
$0.00
+0.00%
 CBDL
CBDL
CBD Life Sciences Inc.
$0.00
+100.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message